The UK government's emergency order banning puberty blockers for transgender minors is unprecedented, leading to potential prison sentences. Restrictions include a grandfather clause for current prescriptions, limiting transitional care.
The ban on puberty blockers affects medications like buserelin, gonadorelin, and leuprorelin acetate, in England, Scotland, and Wales. It excludes Northern Ireland and hormone replacement therapy. The ban lasts from June to September 2024.
Collection
[
|
...
]